Your browser doesn't support javascript.
loading
Durable complete response to immunotherapy with anti-PD-1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report.
Sekido, Katsuhisa; Imaue, Shuichi; Tomihara, Kei; Tachinami, Hidetake; Yamagishi, Kentaro; Okazawa, Seisuke; Ikeda, Atsushi; Fujiwara, Kumiko; Noguchi, Makoto.
Afiliación
  • Sekido K; Department of Oral and Maxillofacial Surgery Faculty of Medicine University of Toyama Toyama City Japan.
  • Imaue S; Department of Oral and Maxillofacial Surgery Toyama Red Cross Hospital Toyama City Japan.
  • Tomihara K; Department of Oral and Maxillofacial Surgery Faculty of Medicine University of Toyama Toyama City Japan.
  • Tachinami H; Department of Oral and Maxillofacial Surgery Faculty of Medicine University of Toyama Toyama City Japan.
  • Yamagishi K; Department of Oral and Maxillofacial Surgery Faculty of Medicine University of Toyama Toyama City Japan.
  • Okazawa S; Department of Radiology Faculty of Medicine University of Toyama Toyama City Japan.
  • Ikeda A; First Department of Internal Medicine Faculty of Medicine University of Toyama Toyama City Japan.
  • Fujiwara K; Department of Oral and Maxillofacial Surgery Faculty of Medicine University of Toyama Toyama City Japan.
  • Noguchi M; Department of Oral and Maxillofacial Surgery Faculty of Medicine University of Toyama Toyama City Japan.
Clin Case Rep ; 9(9): e04545, 2021 Sep.
Article en En | MEDLINE | ID: mdl-34484745
ABSTRACT
Although the optimal treatment method for metastatic oral cancer remains largely unknown, the present case suggests that immunotherapy is a potentially promising alternative for metastatic oral cancer in which other therapies are no longer effective.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Clin Case Rep Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Clin Case Rep Año: 2021 Tipo del documento: Article